Literature DB >> 20067948

Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatment.

Zeev Blumenfeld1, Tsila Zuckerman.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20067948      PMCID: PMC3227878          DOI: 10.1634/theoncologist.2009-0269

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


× No keyword cloud information.
  8 in total

Review 1.  Potential options for preservation of fertility in women.

Authors:  Rogerio A Lobo
Journal:  N Engl J Med       Date:  2005-07-07       Impact factor: 91.245

2.  Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment.

Authors:  Zeev Blumenfeld; Miriam Benaroush; Tsila Zuckerman
Journal:  Hum Reprod       Date:  2007-04-23       Impact factor: 6.918

Review 3.  How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.

Authors:  Zeev Blumenfeld
Journal:  Oncologist       Date:  2007-09

4.  Successful pregnancy following busulfan and cyclophosphamide conditioning and allogeneic bone marrow transplantation for chronic myeloid leukemia.

Authors:  Kleber Matias; Carolina Matias; Heberton Teixeira; Ana Dulce Freire; Alta Azevedo
Journal:  Biol Blood Marrow Transplant       Date:  2008-08       Impact factor: 5.742

5.  Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey.

Authors:  N Salooja; R M Szydlo; G Socie; B Rio; R Chatterjee; P Ljungman; M T Van Lint; R Powles; G Jackson; M Hinterberger-Fischer; H J Kolb; J F Apperley
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

6.  Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.

Authors:  A Carter; L L Robison; L Francisco; D Smith; M Grant; K S Baker; J G Gurney; P B McGlave; D J Weisdorf; S J Forman; S Bhatia
Journal:  Bone Marrow Transplant       Date:  2006-06       Impact factor: 5.483

7.  Four successful pregnancies in a patient with mucopolysaccharidosis type I treated by allogeneic bone marrow transplantation.

Authors:  G Remérand; E Merlin; R Froissart; F Brugnon; J Kanold; L Janny; F Deméocq
Journal:  J Inherit Metab Dis       Date:  2009-03-13       Impact factor: 4.982

8.  Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.

Authors:  Zeev Blumenfeld; Irith Avivi; Ari Eckman; Ron Epelbaum; Jacob M Rowe; Eldad J Dann
Journal:  Fertil Steril       Date:  2007-06-28       Impact factor: 7.329

  8 in total
  6 in total

1.  Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.

Authors:  Zeev Blumenfeld
Journal:  Oncologist       Date:  2012-02-02

2.  Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.

Authors:  Zeev Blumenfeld; Hilli Zur; Eldad J Dann
Journal:  Oncologist       Date:  2015-10-13

Review 3.  Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation.

Authors:  Luminita Nicoleta Cima; Anca Colita; Simona Fica
Journal:  Endocr Connect       Date:  2017-09-25       Impact factor: 3.335

4.  Fertility Preservation in Leukemia.

Authors:  Zeev Blumenfeld
Journal:  Oncologist       Date:  2018-02-07

Review 5.  Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.

Authors:  Zeev Blumenfeld
Journal:  Clin Med Insights Reprod Health       Date:  2019-08-21

Review 6.  GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation.

Authors:  Georgios Valsamakis; Konstantinos Valtetsiotis; Evangelia Charmandari; Irene Lambrinoudaki; Nikolaos F Vlahos
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.